Nuvation Bio is set to launch its first commercial product after the FDA approved its ROS1 inhibitor Ibtrozi as a treatment ...

Type of data available on UK Pharmascan registration, with a breakdown on whether the live record is for a new indication, ...

The companies have said they will create customised AI models and agents that Novo Nordisk can use for early research and ...

While Takeda's Qdenga (TAK-003) shot is approved as a two-dose regimen to protect people from the disease in dozens of countries around the world, the drugmaker withdrew its FDA filing in mid-2023 ...

If that sounds like the storyline to Marvel's latest superhero tale, that's because it is. The publisher's latest custom ...

At ASCO 2025, BioNTech presented 7 abstracts on four selected pipeline candidates in mesothelioma, lung cancer, prostate cancer, and melanoma.

The rate for the latter half of the year brings the full-year average to 23.4% – rising to 24.3% next year and 26% in 2027 – ...

SpliceBio's lead in-house pipeline project is in Stargardt disease, an IRD with no approved therapies that is caused by ...

The pressure to execute a flawless drug or therapy launch has never been greater and continues to lay the foundation for long ...

BMS kickstarted its radiopharma drive last year when it completed a $4.1 billion acquisition of San Diego-based RayzeBio, ...

Makary and Prasad also repeat various themes repeatedly visited by Kennedy on his Make America Healthy Again (MAHA) soapbox, ...

The green light in the US is the first worldwide for Enflonsia ( clesrovimab) and makes the long-acting antibody the first ...